Instructions for Artra (Glucosamine, Chondroitin Sulfate) pills
English product name
Artra
Release form
Coated tablets
Description:
The tablets, covered with a film shell from white to white with a yellowish hue of color, are double-convex, oval, with an engraving "ARTRA" on one side, with a characteristic smell.
1 tab.
mixture substance* 1185 mg, incl:
glucosamine hydrochloride 500 mg
chondroitin sodium sulfate 500 mg
during the production process, a mixture substance consisting of glucosamine hydrochloride and sodium sulphate chondroitin, incorporated in the excess of 525.5 mg (calculated as dry matter) and 613.1 mg (calculated as dry matter), respectively, is used.
Auxiliary substances:
cellulose microcrystalline - 223 mg,
calcium hydrophosphate dihydrate - 125 mg,
sodium croskarmellose - 100 mg,
stearic acid - 50 mg,
magnesium stearate - 17 mg.
Shell Composition:
film coating transparent - 5 mg (hypromellose - 3.75 mg, triacetine - 1.25 mg),
film coating yellow - 35 mg (hypromellose - 10.85 mg,
titanium dioxide - 9.41 mg,
polydextrose - 9.1 mg,
talc - 2.45 mg,
maltodextrin - 1.75 mg,
triglycerides medium-chain - 1.4 mg,
iron oxide yellow - 0.04 mg).
thirty pieces. - high-density polyethylene bottles (1) - cardboard packs.
units - high-density polyethylene bottles (1) - cardboard packs.
one hundred and twenty pcs. - high-density polyethylene bottles (1) - cardboard packs.
ATC codes Artra
M09AX Other preparations for the treatment of diseases of the musculoskeletal system
Clinical-pharmacological groups / Group affiliation
Preparation for stimulating the process of regeneration of cartilage tissue
Active substance Artra
chondroitin sodium sulfate
glucosamine hydrochloride
Pharmacotherapy group
Tissue regeneration stimulator
Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 25 ° C.
Best before date
The shelf life is two years. Do not apply after the expiry date indicated on the package.
Pharmacological effect Artra:
Stimulates cartilage regeneration. Glucosamine and chondroitin sodium sulfate take part in the biosynthesis of connective tissue, contributing to the prevention of cartilage breakdown processes, stimulating tissue regeneration. Introduction of exogenous glucosamine enhances cartilage matrix production and provides non-specific protection, including against NSAIDs and GCS. The preparation has a moderate anti-inflammatory effect.
Chondroitin sodium sulfate, whether absorbed in intactform or as separate components, serves as an additional substrate for the formation of a healthy cartilage matrix. Stimulates the formation of proteoglycans and type II collagen, and protects the cartilage matrix from enzymatic cleavage (by suppressing hyaluronidase activity) and from the damaging effects of free radicals; supports the viscosity of the synovial fluid, stimulates cartilage repair mechanisms and suppresses the activity of those enzymes (elastase, hyaluronidase) that break down cartilage. In the treatment of osteoarthritis eases the symptoms of the disease and reduces the need for NSAIDs.
Testimony Artra:
- osteoarthrosis of peripheral joints and spine.
Method of use, course and dosage:
The drug is taken inside.
Adults and children over 15 years of age are given one tab twice a day for the first three weeks; One tabletka per day for the following weeks and months.
A stable therapeutic effect is achieved when the preparation is administered for at least six months.
Use in children
Children over the age of 15 are prescribed.
- Nosology Artra (ICD codes)
- M15
- Polyarthrosis
- M19.9
- Arthrosis unspecified
- M42
- Spinal osteochondrosis
- M47
- Spondylles
